Evidence for a preferential effect of cyclophosphamide on B-cells.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001402:B-Lymphocytes / Q000187:drug effects*; D003520:Cyclophosphamide / Q000494:pharmacology*; D003877:Dermatitis, Contact / Q000276:immunology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D008198:Lymph Nodes / Q000166:cytology; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009596:Nitrophenols; D010047:Ovalbumin; D012882:Skin Tests; D013154:Spleen / Q000166:cytology / Q000502:physiology; D013156:Splenectomy; D013601:T-Lymphocytes; D014374:Tuberculin Test
D000941:Antigens; D000961:Antilymphocyte Serum; D009596:Nitrophenols; D003520:Cyclophosphamide; D010047:Ovalbumin